172 related articles for article (PubMed ID: 35546653)
1. Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study.
Ezzati A; Fanning KM; Buse DC; Pavlovic JM; Armand CE; Reed ML; Martin VT; Lipton RB
Headache; 2022 Jun; 62(6):755-765. PubMed ID: 35546653
[TBL] [Abstract][Full Text] [Related]
2. Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine.
Ezzati A; Fanning KM; Reed ML; Lipton RB
Headache; 2023 Mar; 63(3):342-352. PubMed ID: 36748728
[TBL] [Abstract][Full Text] [Related]
3. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
4. Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
Ezzati A; Buse DC; Fanning KM; Reed ML; Martin VT; Lipton RB
Clin Neurol Neurosurg; 2022 Dec; 223():107511. PubMed ID: 36395587
[TBL] [Abstract][Full Text] [Related]
5. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
Lipton RB; Munjal S; Buse DC; Bennett A; Fanning KM; Burstein R; Reed ML
Headache; 2017 Jul; 57(7):1026-1040. PubMed ID: 28603893
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine.
Goldstein J; Hoffman HD; Armellino JJ; Battikha JP; Hamelsky SW; Couch J; Blumenthal H; Lipton RB
Cephalalgia; 1999 Sep; 19(7):684-91. PubMed ID: 10524663
[TBL] [Abstract][Full Text] [Related]
7. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
Malik SN; Hopkins M; Young WB; Silberstein SD
Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
[TBL] [Abstract][Full Text] [Related]
8. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
Goldstein J; Silberstein SD; Saper JR; Elkind AH; Smith TR; Gallagher RM; Battikha JP; Hoffman H; Baggish J
Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
Lipton RB; Stewart WF; Ryan RE; Saper J; Silberstein S; Sheftell F
Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
11. The impact of an over-the-counter migraine medication program on quality of life.
Burk CT; Gilderman A; Salas J; Berenbeim D; Nichol MB
Headache; 2003 Mar; 43(3):191-201. PubMed ID: 12603637
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
[TBL] [Abstract][Full Text] [Related]
13. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
14. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
15. Over-the-counter drugs for acute migraine attacks: literature review and recommendations.
Wenzel RG; Sarvis CA; Krause ML
Pharmacotherapy; 2003 Apr; 23(4):494-505. PubMed ID: 12680479
[TBL] [Abstract][Full Text] [Related]
16. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
17. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
Diener HC; Pfaffenrath V; Pageler L; Peil H; Aicher B; Lipton RB
Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
Serrano D; Buse DC; Manack Adams A; Reed ML; Lipton RB
Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676
[TBL] [Abstract][Full Text] [Related]
19. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
[TBL] [Abstract][Full Text] [Related]
20. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
